Science China Life Sciences

, Volume 56, Issue 9, pp 804–810 | Cite as

Green tea catechins prevent obesity through modulation of peroxisome proliferator-activated receptors

  • JingQi Yan
  • Yan Zhao
  • BaoLu ZhaoEmail author
Open Access
Research Paper Progress of Projects Supported by NSFC


Epidemiological evidence and experimental studies suggest that drinking green tea is associated with a lower risk of obesity and related diseases. However, the mechanisms of these effects are not clear. In the present study, we investigated the anti-obesity mechanisms of green tea catechins (GTCs) through modulation of peroxisome proliferator activated-receptor (PPAR) pathways in high-fat diet-induced obesity in rats. GTC supplementation significantly attenuated the increased body and liver weights and the elevated serum and liver triglyceride levels. Meanwhile, GTCs increased the PPARγ levels in subcutaneous white adipose tissue (SWAT) and decreased the PPARγ levels in visceral white adipose tissue (VWAT). In addition, GTC treatment up-regulated the levels of PPARδ in SWAT, VWAT, and brown adipose tissue and increased the expression of genes involved in fatty acid oxidation in brown adipose tissue. Our results suggest that GTCs exert their anti-obesity mechanism in part by modulating PPAR signaling pathways.


obesity green tea catechins peroxisome proliferator activated-receptors (PPARs) hyperlipidemia metabolic syndrome 


  1. 1.
    National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res, 1998, 6(Suppl 2): 51S–209SGoogle Scholar
  2. 2.
    Kopelman P G. Obesity as a medical problem. Nature, 2000, 404: 635–643PubMedGoogle Scholar
  3. 3.
    Dulloo A G, Seydoux J, Girardier L, et al. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord, 2000, 24: 252–258PubMedCrossRefGoogle Scholar
  4. 4.
    Ashida H, Furuyashiki T, Nagayasu H, et al. Anti-obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. Biofactors, 2004, 22: 135–140PubMedCrossRefGoogle Scholar
  5. 5.
    Furuyashiki T, Nagayasu H, Aoki Y, et al. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells. Biosci Biotechnol Biochem, 2004, 68: 2353–2359PubMedCrossRefGoogle Scholar
  6. 6.
    Tokimitsu I. Effects of tea catechins on lipid metabolism and body fat accumulation. Biofactors, 2004, 22: 141–143PubMedCrossRefGoogle Scholar
  7. 7.
    Dufresne C J, Farnworth E R. A review of latest research findings on the health promotion properties of tea. J Nutr Biochem, 2001, 12: 404–421PubMedCrossRefGoogle Scholar
  8. 8.
    Yang M, Wang C, Chen H. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem, 2001, 12: 14–20PubMedCrossRefGoogle Scholar
  9. 9.
    Klaus S, Pultz S, Thone-Reineke C, et al. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond), 2005, 29: 615–623CrossRefGoogle Scholar
  10. 10.
    Nagao T, Komine Y, Soga S, et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr, 2005, 81: 122–129PubMedGoogle Scholar
  11. 11.
    Wang X, Song K S, Guo Q X, et al. The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase. Biochem Pharmacol, 2003, 66: 2039–2047PubMedCrossRefGoogle Scholar
  12. 12.
    Mori M, Hasegawa N. Superoxide dismutase activity enhanced by green tea inhibits lipid accumulation in 3T3-L1 cells. Phytother Res, 2003, 17: 566–567PubMedCrossRefGoogle Scholar
  13. 13.
    Choo J J. Green tea reduces body fat accretion caused by high-fat diet in rats through beta-adrenoceptor activation of thermogenesis in brown adipose tissue. J Nutr Biochem, 2003, 14: 671–676PubMedCrossRefGoogle Scholar
  14. 14.
    Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature, 2000, 405: 421–424PubMedCrossRefGoogle Scholar
  15. 15.
    Rosen E D, Spiegelman B M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem, 2001, 276: 37731–37734PubMedCrossRefGoogle Scholar
  16. 16.
    Wang Y X, Lee C H, Tiep S, et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell, 2003, 113: 159–170PubMedCrossRefGoogle Scholar
  17. 17.
    Mukherjee R, Jow L, Croston G E, et al. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem, 1997, 272: 8071–8076PubMedCrossRefGoogle Scholar
  18. 18.
    Walczak R, Tontonoz P. Setting fat on fire. Nat Med, 2003, 9: 1348–1349PubMedCrossRefGoogle Scholar
  19. 19.
    Lee K. Transactivation of peroxisome proliferator-activated receptor alpha by green tea extracts. J Vet Sci, 2004, 5: 325–330PubMedGoogle Scholar
  20. 20.
    Shimabukuro M, Koyama K, Chen G, et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA, 1997, 94: 4637–4641PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Pappachan J M, Chacko E C, Arunagirinathan G, et al. Management of hypertension and diabetes in obesity: non-pharmacological measures. Int J Hypertens, 2011, 2011: 398065PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Kao Y H, Hiipakka R A, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology, 2000, 141: 980–987PubMedGoogle Scholar
  23. 23.
    Chen N, Bezzina R, Hinch E, et al. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res, 2009, 29: 784–793PubMedCrossRefGoogle Scholar
  24. 24.
    DeFronzo R A. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl, 2004, 9–21Google Scholar
  25. 25.
    Spiegelman B M, Flier J S. Adipogenesis and obesity: rounding out the big picture. Cell, 1996, 87: 377–389PubMedCrossRefGoogle Scholar
  26. 26.
    Tiraby C, Tavernier G, Lefort C, et al. Acquirement of brown fat cell features by human white adipocytes. J Biol Chem, 2003, 278: 33370–33376PubMedCrossRefGoogle Scholar
  27. 27.
    Abe K, Okada N, Tanabe H, et al. Effects of chronic ingestion of catechin-rich green tea on hepatic gene expression of gluconeogenic enzymes in rats. Biomed Res, 2009, 30: 25–29PubMedCrossRefGoogle Scholar
  28. 28.
    Zhao B L, Li X J, He R G, et al. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys, 1989, 14: 175–185PubMedCrossRefGoogle Scholar
  29. 29.
    Guo Q, Zhao B, Li M, et al. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta, 1996, 1304: 210–222PubMedCrossRefGoogle Scholar
  30. 30.
    Guo Q, Zhao B, Shen S, et al. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta, 1999, 1427: 13–23PubMedCrossRefGoogle Scholar
  31. 31.
    Zhao B, Guo Q, Xin W. Free radical scavenging by green tea polyphenols. Methods Enzymol, 2001, 335: 217–231PubMedCrossRefGoogle Scholar
  32. 32.
    Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 2004, 114: 1752–1761PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Bondia-Pons I, Ryan L, Martinez J A. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem, 2012, 68: 701–711PubMedCrossRefGoogle Scholar
  34. 34.
    Keaney J F Jr., Larson M G, Vasan R S, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol, 2003, 23: 434–439PubMedCrossRefGoogle Scholar
  35. 35.
    Nakai M, Fukui Y, Asami S, et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem, 2005, 53: 4593–4598PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2013

Authors and Affiliations

  1. 1.State Key Laboratory of Brain & Cognitive Sciences, Institute of BiophysicsChinese Academy of SciencesBeijingChina
  2. 2.Department of Food Sciences and TechnologyHarbin Institute of Technology at WeihaiWeihaiChina

Personalised recommendations